呼吸威廉亚洲博彩公司

订阅

MedSci主页 / 所有栏目 / 呼吸威廉亚洲博彩公司

2022 GOLD慢性阻塞性肺疾病全球倡议：COPD诊断、治疗与预防全球策略

2021-11-15 慢性阻塞性肺疾病全球倡议 慢性阻塞性肺疾病全球倡议(GOLD)官网

慢性阻塞性肺疾病慢性阻塞性肺疾病与肺心病

2022年GOLDCOPD诊断、治疗与预防全球策略

中文标题：

2022 GOLD慢性阻塞性肺疾病全球倡议：COPD诊断、治疗与预防全球策略

英文标题：

2022 GLOBAL STRATEGY FOR PREVENTION, DIAGNOSIS AND MANAGEMENT OF COPD

发布机构：

慢性阻塞性肺疾病全球倡议

发布日期：

2021-11-15

简要介绍：

2022年GOLDCOPD诊断、治疗与预防全球策略

相关资料下载：
[AttachmentFileName(sort=1, fileName=2022 年黄金袖珍威廉亚洲博彩公司 .pdf), AttachmentFileName(sort=2, fileName=2022 黄金报告.pdf), AttachmentFileName(sort=3, fileName=2022金色教学滑梯套装.pptx)] GetToolGuiderByIdResponse(projectId=1, id=8b4cf1c002263615, title=2022 GOLD慢性阻塞性肺疾病全球倡议：COPD诊断、治疗与预防全球策略, enTitle=2022 GLOBAL STRATEGY FOR PREVENTION, DIAGNOSIS AND MANAGEMENT OF COPD, guiderFrom=慢性阻塞性肺疾病全球倡议(GOLD)官网, authorId=0, author=, summary=2022年GOLDCOPD诊断、治疗与预防全球策略, cover=https://img.medsci.cn/20211115/1636983874542_5579292.jpg, journalId=0, articlesId=null, associationId=202, associationName=慢性阻塞性肺疾病全球倡议, associationIntro=null, copyright=0, guiderPublishedTime=Mon Nov 15 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2022年GOLDCOPD诊断、治疗与预防全球策略</span></p>, tagList=[TagDto(tagId=2115, tagName=慢性阻塞性肺疾病), TagDto(tagId=117733, tagName=慢性阻塞性肺疾病与肺心病)], categoryList=[CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=85, categoryName=威廉亚洲博彩公司 &解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=2115, guiderKeyword=慢性阻塞性肺疾病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=威廉亚洲博彩公司 , guiderLanguage=1, guiderRegion=10, opened=0, paymentType=, paymentAmount=2, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=9326, appHits=949, showAppHits=0, pcHits=3355, showPcHits=8367, likes=4, shares=103, comments=30, approvalStatus=1, publishedTime=Wed Nov 17 00:08:30 CST 2021, publishedTimeString=2021-11-15, pcVisible=1, appVisible=1, editorId=1614372, editor=MedSciZeng, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=5, createdBy=null, createdName=FUNNYMAN, createdTime=Mon Nov 15 22:24:23 CST 2021, updatedBy=1614372, updatedName=MedSciZeng, updatedTime=Sat Jan 06 12:52:05 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2022 年黄金袖珍威廉亚洲博彩公司 .pdf), AttachmentFileName(sort=2, fileName=2022 黄金报告.pdf), AttachmentFileName(sort=3, fileName=2022金色教学滑梯套装.pptx)])
2022 年黄金袖珍威廉亚洲博彩公司 .pdf
下载请点击：
2022 黄金报告.pdf
下载请点击：
2022金色教学滑梯套装.pptx
下载请点击：
评论区 (26)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2157404, encodeId=82cb215e40467, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aaf18786573, createdName=ms4000001364210815, createdTime=Tue Sep 12 21:43:05 CST 2023, time=2023-09-12, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2116910, encodeId=068c2116910a4, content=太好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220428/334968fc6a8f41a7a0097ebac454153d/ee114cc25e594a55aa188e09f9cb7b19.jpg, createdBy=80058133704, createdName=医路有你*, createdTime=Tue Feb 28 16:04:36 CST 2023, time=2023-02-28, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2116951, encodeId=ea6421169515c, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=737c8562988, createdName=ms7000001379242149, createdTime=Tue Feb 28 21:12:30 CST 2023, time=2023-02-28, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2097755, encodeId=05a3209e75549, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20b14243701, createdName=13e2e3cbm26暂无昵称, createdTime=Tue Nov 01 09:29:42 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224261, encodeId=047e1224261c2, content=学到很多东西！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/b1wvblgVe3DzeVwvHZ1RvcUDjV5rdn37aluS21NEb5eH9WE20J7GzMGmZytribqdI1Yz2uSsibpkNVUz608aukFw/132, createdBy=04e95230639, createdName=lichifeng, createdTime=Fri Jun 03 16:19:29 CST 2022, time=2022-06-03, status=1, ipAttribution=)]
    2023-09-12 ms4000001364210815 来自福建省

    学到了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2157404, encodeId=82cb215e40467, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aaf18786573, createdName=ms4000001364210815, createdTime=Tue Sep 12 21:43:05 CST 2023, time=2023-09-12, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2116910, encodeId=068c2116910a4, content=太好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220428/334968fc6a8f41a7a0097ebac454153d/ee114cc25e594a55aa188e09f9cb7b19.jpg, createdBy=80058133704, createdName=医路有你*, createdTime=Tue Feb 28 16:04:36 CST 2023, time=2023-02-28, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2116951, encodeId=ea6421169515c, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=737c8562988, createdName=ms7000001379242149, createdTime=Tue Feb 28 21:12:30 CST 2023, time=2023-02-28, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2097755, encodeId=05a3209e75549, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20b14243701, createdName=13e2e3cbm26暂无昵称, createdTime=Tue Nov 01 09:29:42 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224261, encodeId=047e1224261c2, content=学到很多东西！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/b1wvblgVe3DzeVwvHZ1RvcUDjV5rdn37aluS21NEb5eH9WE20J7GzMGmZytribqdI1Yz2uSsibpkNVUz608aukFw/132, createdBy=04e95230639, createdName=lichifeng, createdTime=Fri Jun 03 16:19:29 CST 2022, time=2022-06-03, status=1, ipAttribution=)]
    2023-02-28 医路有你* 来自河南省

    太好了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2157404, encodeId=82cb215e40467, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aaf18786573, createdName=ms4000001364210815, createdTime=Tue Sep 12 21:43:05 CST 2023, time=2023-09-12, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2116910, encodeId=068c2116910a4, content=太好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220428/334968fc6a8f41a7a0097ebac454153d/ee114cc25e594a55aa188e09f9cb7b19.jpg, createdBy=80058133704, createdName=医路有你*, createdTime=Tue Feb 28 16:04:36 CST 2023, time=2023-02-28, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2116951, encodeId=ea6421169515c, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=737c8562988, createdName=ms7000001379242149, createdTime=Tue Feb 28 21:12:30 CST 2023, time=2023-02-28, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2097755, encodeId=05a3209e75549, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20b14243701, createdName=13e2e3cbm26暂无昵称, createdTime=Tue Nov 01 09:29:42 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224261, encodeId=047e1224261c2, content=学到很多东西！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/b1wvblgVe3DzeVwvHZ1RvcUDjV5rdn37aluS21NEb5eH9WE20J7GzMGmZytribqdI1Yz2uSsibpkNVUz608aukFw/132, createdBy=04e95230639, createdName=lichifeng, createdTime=Fri Jun 03 16:19:29 CST 2022, time=2022-06-03, status=1, ipAttribution=)]
    2023-02-28 ms7000001379242149 来自河南省

    学到了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2157404, encodeId=82cb215e40467, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aaf18786573, createdName=ms4000001364210815, createdTime=Tue Sep 12 21:43:05 CST 2023, time=2023-09-12, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2116910, encodeId=068c2116910a4, content=太好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220428/334968fc6a8f41a7a0097ebac454153d/ee114cc25e594a55aa188e09f9cb7b19.jpg, createdBy=80058133704, createdName=医路有你*, createdTime=Tue Feb 28 16:04:36 CST 2023, time=2023-02-28, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2116951, encodeId=ea6421169515c, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=737c8562988, createdName=ms7000001379242149, createdTime=Tue Feb 28 21:12:30 CST 2023, time=2023-02-28, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2097755, encodeId=05a3209e75549, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20b14243701, createdName=13e2e3cbm26暂无昵称, createdTime=Tue Nov 01 09:29:42 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224261, encodeId=047e1224261c2, content=学到很多东西！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/b1wvblgVe3DzeVwvHZ1RvcUDjV5rdn37aluS21NEb5eH9WE20J7GzMGmZytribqdI1Yz2uSsibpkNVUz608aukFw/132, createdBy=04e95230639, createdName=lichifeng, createdTime=Fri Jun 03 16:19:29 CST 2022, time=2022-06-03, status=1, ipAttribution=)]
    2022-11-01 13e2e3cbm26暂无昵称

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2157404, encodeId=82cb215e40467, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aaf18786573, createdName=ms4000001364210815, createdTime=Tue Sep 12 21:43:05 CST 2023, time=2023-09-12, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2116910, encodeId=068c2116910a4, content=太好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220428/334968fc6a8f41a7a0097ebac454153d/ee114cc25e594a55aa188e09f9cb7b19.jpg, createdBy=80058133704, createdName=医路有你*, createdTime=Tue Feb 28 16:04:36 CST 2023, time=2023-02-28, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2116951, encodeId=ea6421169515c, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=737c8562988, createdName=ms7000001379242149, createdTime=Tue Feb 28 21:12:30 CST 2023, time=2023-02-28, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2097755, encodeId=05a3209e75549, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20b14243701, createdName=13e2e3cbm26暂无昵称, createdTime=Tue Nov 01 09:29:42 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224261, encodeId=047e1224261c2, content=学到很多东西！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/b1wvblgVe3DzeVwvHZ1RvcUDjV5rdn37aluS21NEb5eH9WE20J7GzMGmZytribqdI1Yz2uSsibpkNVUz608aukFw/132, createdBy=04e95230639, createdName=lichifeng, createdTime=Fri Jun 03 16:19:29 CST 2022, time=2022-06-03, status=1, ipAttribution=)]
    2022-06-03 lichifeng

    学到很多东西！

    0

以上为热门评论，williamhill asia 医学App还有更多内容

相关威廉亚洲博彩公司

慢阻肺的护理威廉亚洲博彩公司

暂未更新 · 2021-02-03

慢性阻塞性肺疾病诊治威廉亚洲博彩公司 (2021年修订版)

中华医学会呼吸病学分会慢性阻塞性肺疾病学组 · 2021-03-04

慢性阻塞性肺疾病中医康复威廉亚洲博彩公司

世界中医药学会联合会 · 2020-12-15

2020 ATS临床实践威廉亚洲博彩公司 ：慢性稳定型高碳酸血症性慢性阻塞性肺疾病长期无创通气治疗

美国胸科学会(ATS,American Thoracic Society) · 2020-08-15

2020 ERS威廉亚洲博彩公司 ：慢性阻塞性肺疾病吸入性糖皮质激素停药

欧洲呼吸学会(ERS,European Respiratory Society) · 2020-05-04

国际中医临床实践威廉亚洲博彩公司 ：慢性阻塞性肺疾病

世界中医药学会联合会 · 2020-04-20

拓展阅读

2013年慢性阻塞性肺疾病诊治威廉亚洲博彩公司 （修订版）

中华医学会呼吸病学分会慢性阻塞性肺疾病学组 · 2013-04-01

2014 ACCP/CTS威廉亚洲博彩公司 ：预防慢性阻塞性肺疾病急性发作

美国胸科医师学会(ACCP,American College of Chest Physicians) · 2014-10-16

ICSI：2016慢性阻塞性肺疾病（COPD）的诊断和处理

临床系统改进协会(ICSI,Institute for Clinical Systems Improvement) · 2016-05-12

2013 慢性阻塞性肺疾病诊治威廉亚洲博彩公司 （2013年修订版）

中华医学会呼吸病学分会慢性阻塞性肺疾病学组 · 2014-01-03

慢性阻塞性肺疾病诊断、处理和预防全球策略 (2017GOLD报告)解读

暂未更新 · 2017-01-11

2017 年GOLD慢性阻塞性肺疾病诊断、治疗及预防的全球策略解读

暂未更新 · 2017-01-30